Top

Published in:

01-04-2014 | Short Communication

Efficacy of some colloidal silver preparations and silver salts against Proteus bacteria, one possible cause of rheumatoid arthritis

Authors: D. M. B. T. Disaanayake, Joan Faoagali, Hans Laroo, Gerald Hancock, Michael Whitehouse

Published in: Inflammopharmacology | Issue 2/2014

Abstract

There has been increased interest in the role of anti-Proteus antibodies in the aetiology of rheumatoid arthritis (RA) and whether chemotherapeutic agents active against Proteus species might reduce the risk and/or exacerbations of RA. We examined the in vitro antibacterial effects of ten different silver preparations which were either ionic silver [Ag(I)] solutions or nanoparticulate silver (NPS) (Ag⁰) suspensions against ATCC and two wild (clinical) strains of Proteus. The data establish the low minimum inhibitory concentration and minimum bactericidal concentration of all the silver formulations tested against these four Proteus strains. In a pilot study, a potent NPS preparation ex vivo showed long-lasting anti-Proteus activity in a normal human volunteer.

Chandler RW, Robinson H, Masi AT (1971) Serological investigations for evidence of an infectious aetiology of rheumatoid arthritis. Ann Rheum Dis 30:274–278PubMedCentralPubMedCrossRef

Cock I, van Vuuren SF (2013) Anti-Proteus activity of some South African medicinal plants: their potential for the prevention of rheumatoid arthritis. Inflammopharmacology. doi:10.1007/s10787-013-0179-3 PubMed

Cock I, Mohanty S, White A, Whitehouse M (2012) Colloidal silver (CS) as an antiseptic: two opposing viewpoints. Pharmacog Comm 2:47–56CrossRef

Dayanand S, Dayanand A, Sreedhar B, Dastager SG (2010) Antimicrobial activity of silver nanoparticles synthesized from novel Streptomyces species. Dig J Nanomater Bios 5:447–451

Deighton CM, Gray J, Bint AJ, Walker DJ (1992a) Anti-Proteus antibodies in rheumatoid arthritis same-sexed sibships. Br J Rheumatol 31:241–245PubMedCrossRef

Deighton CM, Gray SW, Bint AJ, Walker DJ (1992b) Specificity of the Proteus antibody response in rheumatoid arthritis. Ann Rheum Dis 51:1206–1207PubMedCentralPubMedCrossRef

Ebringer A (2012) Rheumatoid arthritis and Proteus. Springer, London, p 223

Ebringer A, Rashid T, Wilson C (2003) Rheumatoid arthritis: proposal for the use of antimicrobial therapy in early cases. Scand J Rheumatol 32:2–11PubMedCrossRef

Eckhardt S, Brunetto PS, Gagnon J, Prieve M, Geise B, Fromm KM (2013) Nanobio Silver: its interactions with peptides and bacteria, and its uses in medicine. Chem Rev 113:4708–4754PubMedCrossRef

Fairley KF, Carson NE, Gutch RC, Leighton PO, Grounds AD, Laird EC et al (1971) Site of infection in acute urinary tract infection in general practice. Lancet 2:615PubMedCrossRef

Ferrara P, Romaniello L, Vitelli O, Gatto A, Serva M, Cataldi L (2009) Cranberry juice for the prevention of recurrent urinary tract infections: a randomized controlled trial in children. Scand J Urol Nephrol 43:369–372PubMedCrossRef

Kim JS, Kuk E, Yu KN, Kim J, Park SJ, Lee HJ et al (2007) Antimicrobial effects of silver nanoparticles. Nanomedicine 3:95–101PubMedCrossRef

Laroo H (2013) Colloidal nanosilver—its production method, properties, standards, and its bio-efficacy as an inorganic antibiotic. J Phys Chem Biophys (Omicsonline.org ISSN: 2161-0398)

Lee H, Ko KS, Song JH, Peck KR (2011) Antimicrobial activity of doripenem and other carbapenems against gram-negative pathogens from Korea. Microb Drug Resist 17:37–45PubMedCrossRef

Liu J, Sonshine DA, Shervani S, Hurt RH (2010) Controlled release of biologically active silver from nanosilver surfaces. NANO 4:6903–6913

Lo B (2010) Ethical issues in clinical research: a practical guide. Walters Kluwer, Philadelphia, p 292

Marambio-Jones C, Hoek EMV (2010) A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res 12:1531–1551CrossRef

O’Hara CM, Brenner FW, Miller JM (2000) Classification, identification and clinical significance of Proteus, Providencia and Morganella. Clin Microbiol Rev 13:534–546PubMedCentralPubMedCrossRef

Rashid T, Ebringer A (2007) Rheumatoid arthritis is linked to Proteus—the evidence. Clin Rheumatol 26:1036–1043PubMedCrossRef

Rashid T, Ebringer A (2011) Rheumatoid arthritis is caused by asymptomatic Proteus urinary tract infections. In: Nikibakhsh A (ed) Clinical management of complicated urinary tract infection. In-Tech. vol 11

Rashid T, Tiwana H, Wilson C, Ebringer A (2001) Rheumatoid arthritis as an autoimmune disease caused by Proteus urinary tract infections: a proposal for a therapeutic protocol. Israeli Med Assoc J (IMAJ) 3:675–680

Senior BW, Anderson GA, Morley KD, Ma Kerr (1999) Evidence that patients with rheumatoid arthritis have asymptomatic ‘non-significant’ Proteus mirabilis bacteriuria more frequently than healthy controls. J Infect 8:99–106CrossRef

Sylver N (2009) Handbook of frequency therapy. Desert Gate, Phoenix, p 732

Tiwana H, Wilson C, Cunningham P, Binder A, Ebringer A (1996) Antibodies to four gram-negative bacteria in rheumatoid arthritis which share sequences with the rheumatoid arthritis susceptibility motif. Br J Rheum 35:592–594CrossRef

Varner K, El-Badaway A, Feldhake D, Venkatapathy R (2010) State of the science literature review: everything nanosilver and more. US Environmental Protection Agency, Washington DC, p 363

Whitehouse M, Butters D, Vernon-Roberts B (2013) Conditional pharmacology/toxicology V: ambivalent effects of thiocyanate upon the development and the inhibition of experimental arthritis in rats by aurothiomalate (Myocrysin^R) and metallic silver. Inflammopharmacology 21:291–300PubMedCrossRef

Wilson C, Thakore D, Isenberg D, Ebringber A (1997) Correlation between anti-Proteus antibodies and isolation rates of P. mirabilis in rheumatoid arthritis. Rheumatol Int 16:187–189PubMedCrossRef

Xiu Z-M, Zhang Q-B, Puppala HL, Colvin VL, Alvarez PJJ (2012) Negligible particle-specific antibacterial activity of silver nanoparticles. Nano Lett 12:4271–4275PubMedCrossRef

Title: Efficacy of some colloidal silver preparations and silver salts against Proteus bacteria, one possible cause of rheumatoid arthritis
Authors: D. M. B. T. Disaanayake
Joan Faoagali
Hans Laroo
Gerald Hancock
Michael Whitehouse
Publication date: 01-04-2014
Publisher: Springer Basel
Published in: Inflammopharmacology / Issue 2/2014
Print ISSN: 0925-4692
Electronic ISSN: 1568-5608
DOI: https://doi.org/10.1007/s10787-013-0198-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Efficacy of some colloidal silver preparations and silver salts against Proteus bacteria, one possible cause of rheumatoid arthritis

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2014

Analgesic and antiinflammatory activities of the ethyl acetate fraction of Bidens pilosa (Asteraceae)

Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain

Endocellular regulation by free radicals and hydrogen peroxide: key determinants of the inflammatory response

Oral vitamin D3 supplementation reduces monocyte-derived dendritic cell maturation and cytokine production in Crohn’s disease patients

Emodin elicits cytotoxicity in human lung adenocarcinoma A549 cells through inducing apoptosis

Croton antisyphiliticus Mart. attenuates the inflammatory response to carrageenan-induced pleurisy in mice